Research tools
Analyst Ratings Screener
Find recent upgrades, downgrades, initiations, and reiterations by firm, rating, consensus, target upside, sector, and company size.
Save your best screens
Sign in to keep filters and sorting ready for your next visit.
3,825 matching rating changes
Export CSV| Date, sort lowest first | Symbol | Company | Firm | Action | Prior rating | New rating | Consensus | Analysts, sort highest first | Avg. target | Target upside, sort highest first | Market cap, sort highest first |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 | ABSI | Absci Corporation | BTIG | Main | Buy | Buy | Buy | 15 | $6.00 | -35.28% | 412.02M |
| Sep 8, 2026 | ABT | Abbott Laboratories | TD Cowen | Reiterated | Buy | Buy | Buy | 19 | $151.40 | +48.16% | 202.45B |
| Sep 8, 2026 | ADI | Analog Devices, Inc. | TD Cowen | Reiterated | Buy | Buy | Buy | 24 | $286.38 | -21.03% | 174.21B |
| Sep 8, 2026 | AKBA | Akebia Therapeutics, Inc. | WestPark Capital | Initiated | — | Buy | — | — | $6.50 | +625.85% | 347.63M |
| Sep 8, 2026 | ALNY | Alnylam Pharmaceuticals, Inc. | Jefferies | Main | Hold | Hold | Buy | 20 | $495.36 | +101.77% | 44.15B |
| Sep 8, 2026 | ALV | Autoliv, Inc. | TD Cowen | Downgrade | Buy | Hold | — | — | $136.60 | +16.27% | 9B |
| Sep 8, 2026 | AMGN | Amgen Inc. | BMO Capital | Downgrade | Outperform | Market Perform | Hold | 22 | $368.50 | -2.97% | 209.24B |
| Sep 8, 2026 | AMGN | Amgen Inc. | Cantor Fitzgerald | Reiterated | Neutral | Neutral | Hold | 22 | $368.50 | -2.97% | 209.24B |
| Sep 8, 2026 | ANDG | Andersen | BMO Capital | Initiated | — | Market Perform | — | — | — | — | 2.57B |
| Sep 8, 2026 | ANL | Adlai Nortye Ltd. | HC Wainwright & Co. | Reiterated | Buy | Buy | — | — | $9.00 | -41.10% | 245.52M |
| Sep 8, 2026 | APH | Amphenol Corporation | Barclays | Main | Overweight | Overweight | Buy | 11 | $141.40 | +80.43% | 179.54B |
| Sep 8, 2026 | APP | AppLovin Corporation | BTIG | Main | Buy | Buy | Buy | 20 | $730.55 | +127.16% | 147.09B |
| Sep 8, 2026 | ARWR | Arrowhead Pharmaceuticals, Inc. | Citigroup | Initiated | — | Buy | — | — | $71.00 | +4.81% | 8.86B |
| Sep 8, 2026 | BBY | Best Buy Co., Inc. | DA Davidson | Downgrade | Buy | Neutral | — | — | $83.50 | -11.70% | 15.75B |
| Sep 8, 2026 | BCRX | BioCryst Pharmaceuticals, Inc. | Needham | Reiterated | Buy | Buy | — | — | $14.40 | +65.52% | 1.6B |
| Sep 8, 2026 | BHVN | Biohaven Ltd. | RBC Capital | Downgrade | Outperform | Sector Perform | — | — | $22.50 | +61.99% | 1.21B |
| Sep 8, 2026 | BIOA | BioAge Labs, Inc. | BTIG | Reiterated | Buy | Buy | — | — | $12.00 | +48.33% | 458.05M |
| Sep 8, 2026 | BLTE | Belite Bio, Inc | HC Wainwright & Co. | Main | Buy | Buy | — | — | $191.50 | +12.42% | 5.24B |
| Sep 8, 2026 | BNTX | BioNTech SE | BMO Capital | Downgrade | Outperform | Market Perform | — | — | $144.75 | +46.72% | 23.08B |
| Sep 8, 2026 | CBC | Central Bancompany, Inc. Class A Common Stock | Morgan Stanley | Downgrade | Overweight | Equal-Weight | — | — | — | — | 5.51B |
| Sep 8, 2026 | CBCYB | Central Bancompany, Inc. | Morgan Stanley | Downgrade | Overweight | Equal-Weight | — | — | — | — | 3.83B |
| Sep 8, 2026 | CBSH | Commerce Bancshares, Inc. | Morgan Stanley | Upgrade | Equal-Weight | Overweight | — | — | $65.75 | +14.45% | 7.43B |
| Sep 8, 2026 | CDW | CDW Corporation | Barclays | Main | Equal-Weight | Equal-Weight | Buy | 17 | $174.33 | +16.84% | 19.51B |
| Sep 8, 2026 | CFR | Cullen/Frost Bankers, Inc. | Morgan Stanley | Upgrade | Underweight | Overweight | Hold | 20 | $141.80 | -11.18% | 8.36B |
| Sep 8, 2026 | CHRW | C.H. Robinson Worldwide, Inc. | Citigroup | Upgrade | Neutral | Buy | Buy | 32 | $148.46 | -3.48% | 18.88B |
| Sep 8, 2026 | CL | Colgate-Palmolive Company | RBC Capital | Reiterated | Outperform | Outperform | Buy | 18 | $87.57 | -0.18% | 62.27B |
| Sep 8, 2026 | CLYM | Climb Bio, Inc. | Oppenheimer | Main | Outperform | Outperform | Buy | 12 | $9.38 | -33.26% | 157.17M |
| Sep 8, 2026 | CLYM | Climb Bio, Inc. | HC Wainwright & Co. | Main | Buy | Buy | Buy | 12 | $9.38 | -33.26% | 157.17M |
| Sep 8, 2026 | CMS | CMS Energy Corporation | BMO Capital | Main | Outperform | Outperform | — | — | $78.50 | +18.58% | 20.82B |
| Sep 8, 2026 | CMSA | CMS Energy Corporation 5.6% JRSUB NT 78 | BMO Capital | Main | Outperform | Outperform | — | — | — | — | 6.72B |
| Sep 8, 2026 | CMSC | CMS Energy Corporation 5.875% J | BMO Capital | Main | Outperform | Outperform | — | — | — | — | 7.1B |
| Sep 8, 2026 | CMSD | CMS Energy Corporation 5.875% Junior Subordinated Notes due 2079 | BMO Capital | Main | Outperform | Outperform | — | — | — | — | 7.08B |
| Sep 8, 2026 | COR | Cencora, Inc. | RBC Capital | Reiterated | Sector Perform | Sector Perform | Buy | 14 | $373.17 | +20.61% | 66.71B |
| Sep 8, 2026 | COST | Costco Wholesale Corporation | Freedom Broker | Upgrade | Hold | Buy | Buy | 21 | $1,037.50 | +16.06% | 391.98B |
| Sep 8, 2026 | CPB | Campbell Soup Company | DA Davidson | Main | Neutral | Neutral | — | — | $30.88 | +45.80% | 8.48B |
| Sep 8, 2026 | CPT | Camden Property Trust | Mizuho | Main | Outperform | Outperform | Hold | 30 | $114.97 | +13.91% | 11.09B |
| Sep 8, 2026 | CRCL | Circle Internet Group | Keefe, Bruyette & Woods | Initiated | — | Market Perform | — | — | $121.57 | +42.87% | 20.96B |
| Sep 8, 2026 | CUBB | Customers Bancorp, Inc 5.375% S | Morgan Stanley | Downgrade | Equal-Weight | Underweight | — | — | — | — | 744.18M |
| Sep 8, 2026 | CUBI | Customers Bancorp, Inc. | Morgan Stanley | Downgrade | Equal-Weight | Underweight | — | — | $83.75 | +7.40% | 2.31B |
| Sep 8, 2026 | DASH | DoorDash, Inc. | StoneX | Reiterated | Buy | Buy | Buy | 33 | $298.00 | +53.17% | 96.78B |
| Sep 8, 2026 | DG | Dollar General Corporation | Barclays | Main | Overweight | Overweight | — | — | $133.20 | +6.62% | 29.2B |
| Sep 8, 2026 | DGX | Quest Diagnostics Incorporated | UBS | Main | Neutral | Neutral | Hold | 24 | $201.60 | -18.53% | 20.28B |
| Sep 8, 2026 | DINO | HF Sinclair Corporation | UBS | Main | Buy | Buy | — | — | $59.83 | -48.70% | 9.27B |
| Sep 8, 2026 | DKNG | DraftKings Inc. | Citizens | Main | Market Outperform | Market Outperform | — | — | $49.45 | +120.07% | 17.36B |
| Sep 8, 2026 | DOCS | Doximity, Inc. | Freedom Capital Markets | Downgrade | Buy | Hold | — | — | $71.67 | +169.74% | 8.28B |
| Sep 8, 2026 | EGAN | eGain Corporation | Roth Capital | Downgrade | Buy | Neutral | — | — | — | — | 289.72M |
| Sep 8, 2026 | EGAN | eGain Corporation | B. Riley Securities | Main | Neutral | Neutral | — | — | — | — | 289.72M |
| Sep 8, 2026 | ENGN | enGene Holdings Inc. | HC Wainwright & Co. | Reiterated | Buy | Buy | — | — | $22.67 | +1086.91% | 455.64M |
| Sep 8, 2026 | EQBK | Equity Bancshares, Inc. | Piper Sandler | Main | Overweight | Overweight | — | — | $54.00 | +10.00% | 889.16M |
| Sep 8, 2026 | EQIX | Equinix, Inc. | Barclays | Main | Equal-Weight | Equal-Weight | Buy | 21 | $930.00 | -9.35% | 73.57B |
